FORCESI, EMANUELE
Dettaglio
FORCESI, EMANUELE
DIPARTIMENTO DI SCIENZE MEDICHE E CHIRURGICHE
Pubblicazioni
Risultati 1 - 10 di 10 (tempo di esecuzione: 0.001 secondi).
Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File | |
---|---|---|---|---|---|---|---|
1 | Adverse Events to Food Supplements Containing Red Yeast Rice: Comparative Analysis of FAERS and CAERS Reporting Systems | Raschi, Emanuel*; Girardi, Anna; Poluzzi, Elisabetta; Forcesi, Emanuele; Menniti-Ippolito, France...sca; Mazzanti, Gabriela; De Ponti, Fabrizio | 2018 | DRUG SAFETY | 1.01 Articolo in rivista | - | |
2 | Adverse events with sodium-glucose co-transporter-2 inhibitors: A global analysis of international spontaneous reporting systems | Raschi, E.; Parisotto, M.; Forcesi, E.; La Placa, M.; Marchesini, G.; De Ponti, F.; Poluzzi, E. | 2017 | NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES | 1.01 Articolo in rivista | - | |
3 | Liver injury with drugs used for multiple sclerosis: A contemporary analysis of the FDA Adverse Event Reporting System | Ippazio Cosimo Antonazzo; Elisabetta Poluzzi; Emanuele Forcesi; Trond Riise; Kjetil Bjornevik; El...isa Baldin; Luigi Muratori; Fabrizio De Ponti; Emanuel Raschi | 2019 | MULTIPLE SCLEROSIS | 1.01 Articolo in rivista | - | |
4 | Long-acting injectable antipsychotics: Six-month follow-up of new outpatient treatments in Bologna Community Mental Health Centres | Berardi, Lorenzo; Antonazzo, Ippazio Cosimo; Piccinni, Carlo; Raschi, Emanuel; Forcesi, Emanuele;... Fioritti, Angelo; Berardi, Domenico; De Ponti, Fabrizio; Piazza, Antonella; Poluzzi, Elisabetta* | 2019 | PLOS ONE | 1.01 Articolo in rivista | ||
5 | Multiple sclerosis as an adverse drug reaction: clues from the FDA Adverse Event Reporting System | Antonazzo, Ippazio Cosimo; Raschi, Emanuel; Forcesi, Emanuele; Riise, Trond; Bjornevik, Kjetil; B...aldin, Elisa; De Ponti, Fabrizio; Poluzzi, Elisabetta | 2018 | EXPERT OPINION ON DRUG SAFETY | 1.01 Articolo in rivista | - | |
6 | Myocarditis and pericarditis after immunization: Gaining insights through the Vaccine Adverse Event Reporting System | Mei, Riccardo; Raschi, Emanuel; Forcesi, Emanuele; Diemberger, Igor; De Ponti, Fabrizio; Poluzzi,... Elisabetta | 2018 | INTERNATIONAL JOURNAL OF CARDIOLOGY | 1.01 Articolo in rivista | - | |
7 | Myopathy with DPP-4 inhibitors and statins in the real world: investigating the likelihood of drug–drug interactions through the FDA adverse event reporting system | Antonazzo I.C.; Poluzzi E.; Forcesi E.; Salvo F.; Pariente A.; Marchesini G.; De Ponti F.; Raschi E. | 2020 | ACTA DIABETOLOGICA | 1.01 Articolo in rivista | - | |
8 | Prevalence and determinants of long-term utilization of antidepressant drugs: A retrospective cohort study | Lunghi C.; Antonazzo I.C.; Burato S.; Raschi E.; Zoffoli V.; Forcesi E.; Sangiorgi E.; Menchetti ...M.; Roberge P.; Poluzzi E. | 2020 | NEUROPSYCHIATRIC DISEASE AND TREATMENT | 1.01 Articolo in rivista | - | |
9 | Signal of potentially protective drug–drug interactions from spontaneous reporting systems: proceed with caution | Antonazzo I.C.; Poluzzi E.; Forcesi E.; Salvo F.; Pariente A.; Marchesini G.; De Ponti F.; Raschi E. | 2020 | ACTA DIABETOLOGICA | 1.04 Replica / breve intervento (e simili) | - | |
10 | Toxicities with Immune Checkpoint Inhibitors: Emerging Priorities From Disproportionality Analysis of the FDA Adverse Event Reporting System | Raschi E.; Mazzarella A.; Antonazzo I.C.; Bendinelli N.; Forcesi E.; Tuccori M.; Moretti U.; Polu...zzi E.; De Ponti F. | 2019 | TARGETED ONCOLOGY | 1.01 Articolo in rivista | - |